Dr. Linda Thuy Anh Doan, MD

Dr. Doan practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Doan's NPI, 1225477268, was assigned on June 24, 2013. Dr. Doan graduated from University of California, Irvine, California College of Medicine in 2013. Dr. Doan holds California license 156270.

Dr. Doan's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Doan's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Pathology and Laboratory Services. Dmand AI also links Dr. Doan to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doan practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Doan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Doan is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Doan's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, joint cyst, minor head injury, rash and scalp rash among the conditions Dr. Doan treats.

CMS data shows 3,842 Medicare services from Dr. Doan across 17 procedure codes in 2024, for 1,212 Medicare patients. Medicare paid $218,766 for them.

CMS counts 1,212 Medicare patients who saw Dr. Doan in 2024. The largest group is 75 to 84, with 514 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Doan's median patient age at 63, with 52% women.

In 2024, Dr. Doan wrote 199 Medicare Part D claims for 57 patients. 85% of them were for generic drugs. CMS names the drug for 45 of them, across 2 drugs with 11 or more claims each, at $58,333 in total drug cost. In 2023, CMS named 66 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Doan for performance year 2024, reported through an alternative payment model (APM). Dr. Doan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 79 procedures of removal of skin lesions by Dr. Doan, more than 74% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 52 papers to Dr. Doan, published from 2008 to 2025. 2019 was the busiest year, with 11. The most frequent topics are Skin Neoplasms, Melanoma and Signal Transduction. Dr. Doan has published most often in Am J Dermatopathol. Dr. Doan's most frequent co-authors are Nathan Rojek, MD, Janellen Smith, MD and Allison Sophia Dobry.

CMS Open Payments shows 5 general payments to Dr. Doan from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $247.

Dr. Doan graduated from University of California, Irvine, California College of Medicine in 2013. Dr. Doan is a member of AAD, American Society for Dermatopathology and Women's Dermatologic Society.

Dr. Doan is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.